Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?
Crossref DOI link: https://doi.org/10.1007/s00406-014-0522-8
Published Online: 2014-08-23
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Antel, Jochen
Albayrak, Özgür
Heusch, Gerd
Banaschewski, Tobias
Hebebrand, Johannes
Text and Data Mining valid from 2014-08-23